Publications by authors named "Sittampalam Mara"
Article Synopsis
- - A 30-year-old man with relapsing-remitting multiple sclerosis experienced psoriasiform dermatitis after his second ocrelizumab treatment, which resolved with topical treatments and stopping the medication.
- - There is a rising number of reports linking psoriasiform rashes to ocrelizumab use, potentially caused by B-cell depletion and T-cell overregulation.
- - Currently, skin-related side effects are not addressed in the risk management plans for anti-CD20 therapies like ocrelizumab in multiple sclerosis patients.
